Skip to content

The Science of 47,XYY: Biology and Diagnosis

Last updated:

47,XYY syndrome is a random, non-inherited genetic variation where a male has an extra Y chromosome. While prenatal NIPT can screen for the condition, a definitive diagnosis requires a karyotype or microarray test to confirm the chromosomal difference.

Key Takeaways

  • 47,XYY syndrome is a spontaneous biological event caused by an extra Y chromosome, not an inherited condition.
  • Prenatal NIPT is only a screening tool and requires confirmation through diagnostic tests like amniocentesis or CVS.
  • Postnatal diagnosis is typically confirmed using a karyotype analysis or Chromosomal Microarray (CMA).
  • Some individuals have mosaicism, meaning they carry a mix of 46,XY and 47,XYY cells, which may lead to milder developmental features.

Understanding the genetics of 47,XYY syndrome helps many families move past the “why” and focus on how to best support the future. It is important to know that this condition is not a “disease” in the traditional sense, but rather a chromosomal variation that occurs during the very early stages of development [1][2].

The Biological “Random Event”

Every person typically has 46 chromosomes in each cell. For males, this usually includes one X and one Y chromosome (46,XY). In 47,XYY syndrome, a male has an extra Y chromosome, resulting in a total of 47 [1].

  • How it Happens: This usually occurs because of a random error called nondisjunction. During the formation of sperm cells in the father, the Y chromosomes fail to separate properly [3].
  • Not Your Fault: This is a spontaneous, random biological event. It is not inherited from the parents, and it is not caused by anything either parent did before or during pregnancy [4]. It can happen in any pregnancy, regardless of the parents’ health or lifestyle.

Prenatal Diagnosis and Screening

Many families first learn about the possibility of 47,XYY through prenatal testing. It is vital to understand the difference between a screening and a diagnosis.

  • NIPT (Non-Invasive Prenatal Testing): This is a screening test that analyzes small fragments of DNA in the mother’s blood [5]. While NIPT is very good at identifying potential chromosomal differences, it is not a definitive diagnosis.
  • Why Confirmation is Needed: The Positive Predictive Value (PPV)—the likelihood that a “high risk” result is actually correct—is lower for sex chromosome differences than it is for conditions like Down syndrome [6][7]. A positive NIPT for 47,XYY requires confirmation via an invasive diagnostic test like amniocentesis or chorionic villus sampling (CVS) to be certain [5][8].
  • Biological “False Positives”: Sometimes, a screening test can be influenced by the DNA of the placenta (Confined Placental Mosaicism), which may not perfectly match the DNA of the baby [6][9].

Postnatal Diagnosis

If the condition is not identified during pregnancy, it is usually diagnosed later when a child shows signs like tall stature or speech delays, or when an adult is undergoing fertility workups [10][11].

  • Karyotype Analysis: This is the “gold standard” for diagnosis. A blood sample is taken, and a laboratory technician looks at the chromosomes under a microscope to count them [12][4].
  • Chromosomal Microarray (CMA): This more sensitive test can look for smaller changes in the DNA that a standard karyotype might miss [13]. It is often used if there are more complex symptoms than typical 47,XYY [14].

What is Mosaicism?

In most cases, every cell in the body has the extra Y chromosome. However, some males have mosaicism, meaning they have two or more different types of cells [15][4].

  • 46,XY/47,XYY: Some cells have the standard 46 chromosomes, while others have 47. This is the most common type of mosaicism, and if a large number of cells are 46,XY, the physical and developmental features might be milder [4].
  • Other Rare Variants: Occasionally, a diagnosis might reveal a very rare mosaic pattern, such as 45,X/47,XYY. It is important to know that this is a completely distinct, rare variant related to Turner syndrome lines [4][16]. It can involve radically different challenges (like ambiguous genitalia) that do not apply to standard 47,XYY. If your report shows this, do not panic about standard 47,XYY symptoms; speak with a geneticist about this specific, rare presentation [4].

For more information on how this genetics translates to neurodevelopment, read The Mind and Emotions.

Frequently Asked Questions

Is 47,XYY syndrome inherited from the parents?
No, 47,XYY syndrome is a random biological event that usually occurs due to an error during the formation of sperm cells. It is not inherited, and it is not caused by anything either parent did before or during pregnancy.
Can an NIPT definitively diagnose 47,XYY syndrome?
No, Non-Invasive Prenatal Testing (NIPT) is a screening test that analyzes DNA fragments in the mother's blood. A positive NIPT result for 47,XYY must be confirmed with an invasive diagnostic test, such as an amniocentesis or chorionic villus sampling (CVS).
What does mosaicism mean in a 47,XYY diagnosis?
Mosaicism means a person has two or more different types of cells in their body. In 47,XYY mosaicism, an individual might have a mix of standard 46,XY cells and 47,XYY cells, which can sometimes result in milder physical and developmental features.
How is 47,XYY syndrome diagnosed after birth?
The gold standard for diagnosing the condition after birth is a karyotype analysis, which counts the chromosomes in a blood sample. A Chromosomal Microarray (CMA) may also be used to detect smaller, more complex DNA changes that a karyotype might miss.

Questions for Your Doctor

  • Was the diagnosis based on a screening test (NIPT) or a diagnostic test (karyotype)?
  • Does the genetic report show any evidence of mosaicism or different cell lines?
  • How does the diagnosis of 47,XYY impact the likelihood of other genetic conditions?
  • Should we pursue Chromosomal Microarray (CMA) to look for any other smaller genetic changes?

Questions for You

  • How do I feel knowing that this was a random event and not something passed down?
  • Am I comfortable with the difference between a screening and a diagnostic test?
  • What questions about future health and fertility are most on my mind after learning about the genetics of this condition?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Gonadal function in patients with 47,XYY syndrome: a systematic review and meta-analysis.

    Cannarella R, Pedano A, Compagnone M, et al.

    Endocrine connections 2025; (14(4)).

    PMID: 39981656
  2. 2

    Jacob's Syndrome and Hearing Loss: A Case Study.

    Bagheri H, Kouhi A, Alidoust M, Koravand A

    Clinical case reports 2026; (14(3)):e72143 doi:10.1002/ccr3.72143.

    PMID: 41767059
  3. 3

    Double Aneuploidy of Down Syndrome (Trisomy 21) and Jacobs Syndrome (Trisomy XYY) with Complete Tracheal Rings Deformity: Case Report and Literature Review.

    Adeleke O, Elmufti H, Zhang J, et al.

    AJP reports 2023; (13(4)):e53-e60 doi:10.1055/s-0043-1774728.

    PMID: 37937269
  4. 4

    Can Individuals with 47,XYY Karyotypes Exist without Male Phenotype? A Narrative Literature Review and Case Report.

    Pires MJ, Teixeira LC, Angeloni LL, et al.

    Frontiers in bioscience (Scholar edition) 2025; (17(1)):25251 doi:10.31083/FBS25251.

    PMID: 40150868
  5. 5

    Amniotic fluid stem cells and the cell source repertoire for non-invasive prenatal testing.

    Rosner M, Kolbe T, Voronin V, Hengstschläger M

    Stem cell reviews and reports 2022; (18(4)):1366-1371 doi:10.1007/s12015-021-10228-5.

    PMID: 34383184
  6. 6

    Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.

    Liu Y, Liu H, He Y, et al.

    Human genomics 2020; (14(1)):21 doi:10.1186/s40246-020-00268-2.

    PMID: 32503639
  7. 7

    Clinical evaluation of noninvasive prenatal testing for sex chromosome aneuploidies in 9,176 Korean pregnant women: a single-center retrospective study.

    Kim H, Park JE, Kang KM, et al.

    BMC pregnancy and childbirth 2024; (24(1)):93 doi:10.1186/s12884-024-06275-8.

    PMID: 38297236
  8. 8

    Cell-free DNA screening for sex chromosome aneuploidies by non-invasive prenatal testing in maternal plasma.

    Wang Y, Li S, Wang W, et al.

    Molecular cytogenetics 2020; (13()):10 doi:10.1186/s13039-020-0478-5.

    PMID: 32190123
  9. 9

    Prenatal diagnosis after high chance non-invasive prenatal testing for trisomies 21, 18 and 13, chorionic villus sampling or amniocentesis? - Experience at a district general hospital in the United Kingdom.

    Okoror CEM, Arora S

    European journal of obstetrics & gynecology and reproductive biology: X 2023; (19()):100211 doi:10.1016/j.eurox.2023.100211.

    PMID: 37456970
  10. 10

    Morbidity, mortality, and socioeconomics in Klinefelter syndrome and 47,XYY syndrome: a comparative review.

    Ridder LO, Berglund A, Stochholm K, et al.

    Endocrine connections 2023; (12(5)).

    PMID: 37098811
  11. 11

    Clinical aspects of infertile 47,XYY patients: a retrospective study.

    Borjian Boroujeni P, Sabbaghian M, Vosough Dizaji A, et al.

    Human fertility (Cambridge, England) 2019; (22(2)):88-93 doi:10.1080/14647273.2017.1353143.

    PMID: 28715980
  12. 12

    Genetic investigations on causes of male infertility in Western Saudi Arabia.

    Beg MA, Nieschlag E, Abdel-Meguid TA, et al.

    Andrologia 2019; (51(6)):e13272 doi:10.1111/and.13272.

    PMID: 30907014
  13. 13

    Prenatal diagnosis of non-mosaic sex chromosome abnormalities: a 10-year experience from a tertiary referral center.

    Wu X, Guo D, Li Y, et al.

    Journal of perinatal medicine 2023; (51(7)):904-912 doi:10.1515/jpm-2022-0552.

    PMID: 37138453
  14. 14

    Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication.

    Tian W, Yuan Y, Yuan E, et al.

    European journal of medical research 2023; (28(1)):304 doi:10.1186/s40001-023-01285-2.

    PMID: 37644576
  15. 15

    A patient with 46,XY/47,XYY karyotype and female phenotype: a case report.

    Liu ZH, Zhou SC, Du JW, et al.

    BMC endocrine disorders 2020; (20(1)):42 doi:10.1186/s12902-020-0523-8.

    PMID: 32209072
  16. 16

    45,X mosaicism with Y chromosome presenting female phenotype.

    Fukui S, Watanabe M, Yoshino K

    Journal of pediatric surgery 2015; (50(7)):1220-3.

    PMID: 26002715

This page explains the genetics and diagnosis of 47,XYY syndrome for educational purposes only. Always consult a genetic counselor or healthcare provider to interpret your specific prenatal or postnatal test results.

Stay up to date

Get notified when new research about 47,XYY syndrome is published.

No spam. Unsubscribe anytime.